Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pacific Biosciences of California

1.14
-0.0300-2.56%
Post-market: 1.140.00000.00%19:59 EDT
Volume:6.84M
Turnover:7.88M
Market Cap:339.55M
PE:-1.01
High:1.19
Open:1.18
Low:1.13
Close:1.17
Loading ...

Company Profile

Company Name:
Pacific Biosciences of California
Exchange:
NASDAQ
Establishment Date:
2000
Employees:
575
Office Location:
1305 O’Brien Drive,Menlo Park,California,United States
Zip Code:
94025
Fax:
- -
Introduction:
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Directors

Name
Position
Christian O. Henry
Chairman of the Board,Director
Michael Hunkapiller
President, Chief Executive Officer and Director
David Botstein
Director
John F. Milligan
Director
Kathy Ordonez
Director
Lucy Shapiro
Director
Marshall L. Mohr
Director
Randy Livingston
Director
William Ericson
Director

Shareholders

Name
Position
Michael Hunkapiller
President, Chief Executive Officer and Director
Denis Zaccarin
Senior Vice President, Research and Development
Susan K. Barnes
Executive Vice President, Chief Financial Officer
Chris Seipert
Vice President